Paper26315743
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Piazza G and 27 others. JACC Cardiovasc Interv, 2015. Cited by 793 papers, by iCite.
Cite this record
ConductScience Library. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. Papers, record 26315743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26315743
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catheterization, Peripheral | Major topic |
| Fibrinolytic Agents | Major topic |
| Pulmonary Embolism | Major topic |
| Thrombolytic Therapy | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Ultrasonic Therapy | Major topic |
| Acute Disease | |
| Adult | |
| Aged | |
| Equipment Design | |
| Female | |
| Hemorrhage | |
| Humans | |
| Hypertension, Pulmonary | |
| Hypertrophy, Right Ventricular | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Risk Factors | |
| Severity of Illness Index | |
| Time Factors | |
| Tomography, X-Ray Computed | |
| Treatment Outcome | |
| United States | |
| Vascular Access Devices |
Source PubMed
Trials9
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01513759 | Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT03341208 | Quantitative Assessment of RV Strain Using cMRI Following Catheter Intervention on PE | Background | ClinicalTrials.gov | |
| NCT03465735 | Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE) | Background | ClinicalTrials.gov | |
| NCT03581877 | Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE | Background | ClinicalTrials.gov | |
| NCT03988842 | Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism | Background | ClinicalTrials.gov | |
| NCT04113421 | Quantitative 3-Dimensional Chest CT Vascular Reconstruction Before and After Anticoagulation for Pulmonary Embolism | Background | ClinicalTrials.gov | |
| NCT04480892 | Fibrinolytic Deficit in Patients With Acute PE | Background | ClinicalTrials.gov | |
| NCT04790370 | Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism | Background | ClinicalTrials.gov | |
| NCT05493163 | Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26315744 | Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand? | https://conductscience.org/library/papers/26315744 |
Source PubMed
Cited by404
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 793 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985536 | Integrated management of acute pulmonary embolism and the post-pulmonary embolism syndrome: risk stratification, modern therapies, and long-term follow-up. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42985536 | PubMed |
| 42952484 | Large-bore Mechanical Thrombectomy for Treatment of Intermediate-high Risk Pulmonary Embolism: A Single-center Australian Experience. | Interv Radiol (Higashimatsuyama) | 2026 | https://conductscience.org/library/papers/42952484 | PubMed |
| 42936544 | Cost-Effectiveness of Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis. | J Soc Cardiovasc Angiogr Interv | 2026 | https://conductscience.org/library/papers/42936544 | PubMed |
| 42795929 | Early Outcomes of Bolus Thrombolysis Plus Manual Aspiration Thrombectomy Using Conventional Catheters for Intermediate-High- and High-Risk Acute Pulmonary Embolism. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795929 | PubMed |
| 42795908 | Subacute Pulmonary Embolism: Insights from a National Registry of Catheter-Directed Interventions. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795908 | PubMed |
| 42792675 | Optimal Duration of Ultrasound-Facilitated Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: A Retrospective Cohort Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792675 | PubMed |
| 42788608 | Beyond Baseline: Dynamic Prognostic Assessment in Acute Pulmonary Embolism. | Arq Bras Cardiol | 2026 | https://conductscience.org/library/papers/42788608 | PubMed |
| 42788551 | Persistent Right Ventricular Dysfunction and Hemodynamic Evolution Predict In-Hospital Deterioration in Intermediate-High- and High-Risk Pulmonary Embolism. | Arq Bras Cardiol | 2026 | https://conductscience.org/library/papers/42788551 | PubMed |
| 42740760 | Treatment with the EkoSonic™ Endovascular System (EKOS®): initial experience in Brazil and technical tips and tricks - a case series report. | Respir Res Clin Pract | 2026 | https://conductscience.org/library/papers/42740760 | PubMed |
| 42662835 | Reviving the Standstill Heart: Multimodal Management of Refractory Cardiac Arrest due to Massive Pulmonary Embolism. | Case Rep Crit Care | 2026 | https://conductscience.org/library/papers/42662835 | PubMed |
| 42657006 | Outcomes of catheter-directed mechanical thrombectomy in patients with cancer-associated pulmonary embolism: a multicenter, prospective registry. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42657006 | PubMed |
| 42625636 | Thrombus aspiration and in situ thrombolysis via a 6F Guidezilla catheter in elderly patients with high-risk pulmonary embolism: a case series of six patients. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42625636 | PubMed |
| 42584509 | Unplanned 6-month readmissions and in-hospital outcomes for the management of acute intermediate- and high-risk pulmonary embolism: comparisons of endovascular interventions. | CVIR Endovasc | 2026 | https://conductscience.org/library/papers/42584509 | PubMed |
| 42583344 | Percutaneous mechanical thrombectomy using the AcoStream thrombus aspiration system for intermediate-high-risk pulmonary embolism. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42583344 | PubMed |
| 42548515 | Outcomes Associated With Catheter-Directed Therapies in Chronic Thromboembolic Pulmonary Hypertension: Cautionary Tales From a Single-Center Case Series. | CHEST Pulm | 2023 | https://conductscience.org/library/papers/42548515 | PubMed |
| 42514256 | Predictors of 90-Day Mortality and the Association of Reperfusion Therapy with 90-Day Mortality in Intermediate-High and High-Risk Pulmonary Embolism: A Real-World Multidisciplinary Cohort Study. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42514256 | PubMed |
| 42469156 | Catheter-Based Therapies for Intermediate-High Risk Pulmonary Embolism: A Protocol for a Systematic Review With Bayesian Pairwise and Network Meta-Analyses. | Acta Anaesthesiol Scand | 2026 | https://conductscience.org/library/papers/42469156 | PubMed |
| 42452503 | Interventional Management of Intermediate-High-Risk Pulmonary Embolism: Current Evidence, Patient Selection and Personalised Treatment Strategies. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452503 | PubMed |
| 42447143 | Pulmonary embolism consensus. | Arch Cardiol Mex | 2026 | https://conductscience.org/library/papers/42447143 | PubMed |
| 42444911 | Mechanical thrombectomy in intermediate-high risk pulmonary embolism: progress, promise, and remaining uncertainty. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444911 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26315743
GET https://conductscience.org/api/papers/v1/26315743/authors?page=2